Skip to main content
Equibles
CRNX $84.70 +0.31%
CRNX logo

CRNX · Crinetics Pharmaceuticals, Inc.

Track CRNX — free

Use CRNX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CRNX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$84.70 +0.26 (+0.31%) At close · Aug 14
Market Cap
$8.98B
Shares
106.07M
All earnings calls

Earnings call · FY2026 Q2

Webcast: Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results

Webcast: Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results

Concluded Aug 4, 2026
Aug 4, 2026 0 turns
Period
FY2026 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $25.12M +2336.3% YoY
Diluted EPS -$1.14
Net income -$120.86M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 3, 2026 10-Q report Filed Aug 3, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$24.04M
License And Service$1.08M +4.8% YoY
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)